T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SINA
1001
DELISTED
Sina Corp
SINA
| $31M | 0.01% |
963,900
-4,200
| -0.4% | -$151K |
|
1002
TransDigm Group
TDG
$68.8B
| $31M | 0.01% |
141,654
-1,400
| -1% | -$295K |
|
1003
Modine Manufacturing
MOD
$10.8B
| $31M | 0.01% |
2,298,150
-95,700
| -4% | -$1.23M |
|
|
NCI
1004
DELISTED
Navigant Consulting, Inc.
NCI
| $30.9M | 0.01% |
2,381,300
+4,890
| +0.2% | +$69.4K |
|
1005
Visteon
VC
$2.85B
| $30.8M | 0.01% |
319,960
-60,030
| -16% | -$5.99M |
|
1006
Old Dominion Freight Line
ODFL
$45.1B
| $30.8M | 0.01% |
1,193,499
+57,018
| +5% | +$1.44M |
|
1007
Consolidated Edison
ED
$40B
| $30.7M | 0.01% |
504,064
+12,090
| +2% | +$785K |
|
1008
COPT Defense Properties
CDP
$4.22B
| $30.7M | 0.01% |
1,044,590
+920,280
| +740% | +$27.2M |
|
|
SAVE
1009
DELISTED
Spirit Airlines, Inc.
SAVE
| $30.7M | 0.01% |
396,465
-1,195
| -0.3% | -$91.7K |
|
1010
Astec Industries
ASTE
$973M
| $30.7M | 0.01% |
715,140
-207,650
| -23% | -$8.21M |
|
1011
Hartford Financial Services
HIG
$37.8B
| $30.3M | 0.01% |
725,524
+6,600
| +0.9% | +$271K |
|
|
KYNB
1012
Kyntra Bio
KYNB
$28.6M
| $30.3M | 0.01% |
39,097
-52
| -0.1% | -$40.3K |
|
|
INOV
1013
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $30M | 0.01% |
+993,700
| New | +$29.8M |
|
1014
Agnico Eagle Mines
AEM
$91.3B
| $29.9M | 0.01% |
1,074,750
-3,370
| -0.3% | -$104K |
|
1015
American Public Education
APEI
$835M
| $29.4M | 0.01% |
979,610
+202,400
| +26% | +$6.75M |
|
1016
Parker-Hannifin
PH
$133B
| $29.3M | 0.01% |
246,765
+1,280
| +0.5% | +$155K |
|
1017
Avient
AVNT
$4.22B
| $29.3M | 0.01% |
783,960
+298,530
| +61% | +$11.3M |
|
1018
Team
TISI
$101M
| $29.2M | 0.01% |
75,026
+1,099
| +1% | +$421K |
|
|
CTRA
1019
DELISTED
Coterra Energy
CTRA
| $28.8M | 0.01% |
973,965
+17,170
| +2% | +$487K |
|
1020
Whirlpool
WHR
$2.81B
| $28.6M | 0.01% |
141,685
-305,795
| -68% | -$62.1M |
|
1021
Domino's
DPZ
$11.7B
| $28.5M | 0.01% |
283,778
+11,453
| +4% | +$1.15M |
|
1022
Rockwell Automation
ROK
$49.6B
| $28.5M | 0.01% |
245,820
+3,200
| +1% | +$360K |
|
|
X
1023
DELISTED
US Steel
X
| $28.4M | 0.01% |
1,162,691
-798,335
| -41% | -$18.9M |
|
|
LXFT
1024
DELISTED
Luxoft Holding, Inc.
LXFT
| $28.1M | 0.01% |
543,257
+9,025
| +2% | +$411K |
|
1025
CTS Corp
CTS
$1.78B
| $28M | 0.01% |
1,558,790
+62,780
| +4% | +$1.07M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.